Pacira Pharmaceuticals
Focuses on the development, commercialization, and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. The company went public in February 2011.
2011 STATISTICS
3-year growth:75%
2010 Revenue:$14.6 million
2007 Revenue:$8.3 million
Employees:83